arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

RETRACTABLE TECHNOLOGIES INC

RVP
$0.69 ▲ +0.01 (+1.71%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
68 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
29
Health
Poor
Moderately Bearish
auto_awesome

Analytical Summary

RETRACTABLE TECHNOLOGIES INC faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). On the positive side, Debt to Equity remains strong. Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $20.7M
Dividend Yield
Revenue Growth -31.1%
Op. Margin -71.5%
ROIC -7.1%
FCF / Share $-0.06
Trailing P/E 7.7x
Price / Book 0.3x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$7.20M
↓ -31.1%
Net Income Profit after all expenses
$2.83M
↑ +167.0%
Operating Margin Operating profit as % of sales
-71.5%
↑ +16.8% 5th
FCF / Share Free cash flow per share
$-0.06
↓ -28.2%
Long-Term Debt Long-term obligations
$895.64K
↑ +43.6%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
7
Returns
29
Financial Health
51
Cash Quality
43

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 18 years · 68 quarters